Ações da Bayer caem vítimas do glifossato
May 15, 2019 -- Decisões judiciais adversas retiraram mais de 40% ao valor de mercado
da Bayer desde agosto de 2018, com o grupo farmacêutico alemão
obrigado a pagar indemnizações pelos seus herbicidas com glifossato.
A jury in California on Monday awarded more than $2bn to a couple who said the weedkiller Roundup was responsible for their cancer.
It is the third time that the German pharmaceutical group Bayer has been ordered to pay damages over its glyphosate-based herbicide.
Bayer, which acquired Roundup maker Monsanto for $63 billion last year, denies the allegations, saying decades of studies and regulatory approvals have shown glyphosate and Roundup to be safe for human use.
But the company faces similar U.S. lawsuits by more than 13,400 plaintiffs and shareholders have rebuked Bayer’s top management over its handling of the Monsanto acquisition and the litigation it inherited.